Home Chronic disease

Keyword: Chronic disease

117 results found

With Canada’s public and private drug market an ever-evolving landscape, what value can be gained from collaboration and innovative solutions to ensure patient access to new medicines and vaccines in the future? During Innovative Medicines Canada’s virtual policy summit in June, Declan Hamill, vice-president of policy, regulatory and legal affairs, said the organization appreciates the […]

Copyright_Aleksandr Kalugin_123RF

Canadians’ health priorities are shifting as the coronavirus pandemic drags on, as claims for medications to treat mental-health conditions continued to rise in 2020, along with claims for specialty drugs designed to treat rarer, yet increasingly chronic diseases, according to Telus Health’s annual drug trends report. There were noticeable shifts in the utilization of mental-health […]

Employee off-hours conduct during coronavirus pandemic leading to dismissals

Canadian employees with ongoing health challenges have faced unique challenges during the coronavirus pandemic, according to a new survey by RBC Insurance. Among employees with a chronic health condition, 63 per cent said the inability to visit a doctor or clinic during the pandemic negatively impacted their health, compared to 47 per cent of those without […]

  • By: Staff
  • June 3, 2021 June 4, 2021
  • 15:00

Substance use disorder is the largest unmanaged disease in modern health care, but few options exist that allow those affected to continue to work while being treated and that address plan members whose substance use issues aren’t visible in the workplace. “The overwhelming majority of substance use cases is invisible to the eye,” said Elliot […]

Copyright_Pop Nukoonrat_123RF

Half of Canadians said they’ve increased their use of virtual health care since the beginning of the coronavirus pandemic, according to a new survey by consulting firm Calian Group Ltd. It also found, while 49 per cent of respondents said they intend to continue using virtual care after the pandemic is over and safety precautions […]

  • By: Staff
  • May 26, 2021 May 26, 2021
  • 15:00

The growing use of specialty medications among plan members continued to drive the increase in plan sponsors’ drug plan costs last year, well eclipsing the increase in traditional drug spending, according to Telus Health. Canadian plan sponsors’ drug spending on insured plan members between the ages of 25 and 64 increased 3.6 per cent in […]

While the rates of drug and disability claims are returning to their pre-pandemic levels, employers are still contending with the impact of the coronavirus crisis on their benefits plans. Following the declaration of the pandemic in March 2020, there was a subsequent surge in drug claims attributed to medication stockpiling, said Frédéric Leblanc, strategic advisor […]

Last February, Carolyne Eagan’s mother was suddenly stricken with an excruciatingly painful condition called trigeminal neuralgia, which prevented her from eating, talking or drinking without triggering a flare of pain in her head. Eagan gathered up her mom’s medications and got into the ambulance with her, feeling increasingly distressed as she wasn’t able to answer […]

Approximately 10 per cent of Canadians live with diabetes and one in 300 children live with Type 1 diabetes, according to Dr. Angelo Simone, a paediatric endocrinologist at Trillium Health Partners, during a webinar hosted by Benefits Canada and sponsored by Abbott in April. As a parent caring for two children living with Type 1 […]

Copyright_Mikhail Tsikhanovich_123RF

The New Brunswick government is expanding the use of biosimilars for certain chronic conditions in its public drug plans. Approximately 3,000 beneficiaries of the province’s drug plans who are living with diseases such as inflammatory arthritis, inflammatory bowel disease, diabetes and psoriasis will have until Nov. 30 to switch from a biologic to the biosimilar […]

  • By: Staff
  • April 23, 2021 April 26, 2021
  • 15:00